Carboplatin and Immunodeficiency disorders - a phase IV clinical study of FDA data

Summary:

Immunodeficiency disorders is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Etoposide, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Immunodeficiency disorders when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.

What is Carboplatin?

Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.

What is Immunodeficiency disorders?

Immunodeficiency disorders is found to be associated with 708 drugs and 941 conditions by eHealthMe. Check the latest studies of Immunodeficiency disorders.

On Jul, 05, 2026

127,949 people reported to have side effects when taking Carboplatin.
Among them, 90 people (0.07%) have Immunodeficiency disorders.

Could Carboplatin cause Immunodeficiency disorders?

Among these 90 people:

How long have people been on Carboplatin when they have Immunodeficiency disorders? *

What is the gender of people who have Immunodeficiency disorders when taking Carboplatin? *

female: 38.37 %
male: 61.63 %

What is the age of people who have Immunodeficiency disorders when taking Carboplatin? *

What are other drugs people take besides Carboplatin? *

What are other side effects people have besides Immunodeficiency disorders? *

Kaposi's Sarcoma (a tumour caused by human herpes virus): 26 people, 28.89%
Tinnitus (a ringing in the ears): 24 people, 26.67%
Human Herpesvirus 8 Infection: 24 people, 26.67%
Febrile Neutropenia (fever with reduced white blood cells): 15 people, 16.67%
Fever: 12 people, 13.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 12 people, 13.33%
Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 12.22%
Amaurosis (partial or total blindness without visible change in the eye): 10 people, 11.11%
Escherichia Sepsis (bacterial infection by escherichia coli): 10 people, 11.11%
Bacterial Pyelonephritis (bacterial kidney infection): 9 people, 10.00%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 29 people, 32.22%
High Blood Pressure: 26 people, 28.89%
Kaposi's Sarcoma (a tumour caused by human herpes virus): 20 people, 22.22%
Haematopoietic Stem Cell Mobilisation: 14 people, 15.56%
Cytomegalovirus Test Positive: 13 people, 14.44%
Cytomegalovirus Infection: 13 people, 14.44%
Lung Neoplasm Malignant (cancer tumour of lung): 5 people, 5.56%
Neoplasm Malignant (cancer tumour): 3 people, 3.33%
Psychotic Disorder: 3 people, 3.33%
Angioimmunoblastic T-Cell Lymphoma (mature t-cell cancer of the blood or lymph vessel): 2 people, 2.22%

* Approximation only. Some reports may have incomplete information.

Do you take Carboplatin and have Immunodeficiency disorders?

- Check whether Immunodeficiency disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carboplatin:

Carboplatin (128,210 reports)

Browse all side effects of Carboplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Immunodeficiency disorders:

Immunodeficiency disorders (708 drugs)

Browse all the conditions that are associated with Immunodeficiency disorders:

Immunodeficiency disorders (941 conditions)

Related publications that referenced our studies

Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.